Sign inJoin waitlistJoin the waitlist

XY

Xiaohong Yan

Specialist/Technologist

Credentials: ·

Research

Adagrasib in Non-Small-Cell Lung Cancer Harboring a KRASG12C Mutation
New England Journal of Medicine · 2022 · 871 citations
First-in-Human Phase I/IB Dose-Finding Study of Adagrasib (MRTX849) in Patients With Advanced KRASG12C Solid Tumors (KRYSTAL-1)
Journal of Clinical Oncology · 2022 · 277 citations
Adagrasib in Advanced Solid Tumors Harboring a KRASG12C Mutation
Journal of Clinical Oncology · 2023 · 271 citations

Richard Whelan
28 papers
EP
Erica Pettke
6 papers · 5 as a resident
AS
Abhinit Shah
5 papers · 4 as a resident
DK
Daniel Kirchoff
5 papers · 4 as a resident
Richard Chao
5 papers
AS
Alexander Spira
4 papers
Geoffrey Bellini
4 papers · 4 as a fellow
Joshua Sabari
4 papers
Lyudmila Bazhenova
4 papers
Matthew Kalady
4 papers
Michael Grieco
4 papers · 4 as a resident
Nipa Gandhi
4 papers